Suspicion of allergic or anaphylactic type reactions requires immediate discontinuation of inj. Caution in conditions where hypervolaemia & its consequences or haemodilution could represent a special patient risk. Adequate hydration in patients when concentrated albumin is administered; monitor carefully to guard against circulatory overload & hyperhydration. Monitor patient's electrolyte status. Do not dilute w/ water for inj as this may cause haemolysis in recipients. Control coagulation & haematocrit if comparatively large vol are to be replaced. Hypervolaemia may occur if dosage & rate of infusion are not adjusted to patient's circulatory situation; immediately stop infusion at the 1st clinical signs of CV overload (headache, dyspnoea, jugular vein congestion), or increased BP, raised central venous pressure & pulmonary oedema. Patients on a controlled Na diet.